Salvianolic acid B, a new type I <scp>IRE1</scp> kinase inhibitor, abrogates <scp>AngII</scp> ‐induced angiogenesis by interacting with <scp>IRE1</scp> in its active conformation-Reference-Cited by-同舟云学术

Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII ‐induced angiogenesis by interacting with IRE1 in its active conformation

Author:

Fan Fangtian¹,Liu Fang¹,Shen Peiliang²,Tao Li³,Zhang Hongjiang⁴,Wu Hongyan⁵^ORCID

Affiliation:

1. Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals School of Pharmacy Bengbu Medical College Bengbu China

2. School of Medicine & Holistic Integrative Medicine Nanjing University of Chinese Medicine Nanjing China

3. School of Medicine Yangzhou University Yangzhou China

4. Department of Pharmacology Nanjing University of Chinese Medicine Hanlin College Taizhou China

5. Institute of Biomedical Technology Jiangsu Vocational College of Medicine Yancheng China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

Reference35 articles.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献